openPR Logo
Press release

Global Fiducial Markers Market to Expand at over 8% CAGR Through 2031 | Eckert & Zieglar BEBIG, Innovative Oncology Solutions, Boston Scientific

04-10-2021 10:21 AM CET | Health & Medicine

Press release from: Fact.MR

Fiducial markers, tiny metal objects about the size of a grain of rice, are highly efficient in pinpointing the location of a tumor with high precision. As fiducial markers are an integral part of radiation therapy to target tumors without affecting nearby healthy tissues, they have high requirement in the healthcare and medical sectors. According to Fact.MR, the global fiducial markers market is set to expand at over 8% CAGR through 2031.

Click here to Get Synopsis of the Report- https://www.factmr.com/report/1026/fiducial-marker-market

With the adoption of fiducial markers as a standard tool for image-guided radiotherapy, manufacturers are coming across huge demand. According to a report titled “Radiotherapy in Global Cancer Control” published by the Cancer Control Organization, availability of radiotherapy equipment varied from 8.6 machines per million people in high-income countries (as per the World Bank definition) to 1.6 per million in high-middle income, 0.71 in low-middle income countries, and 0.21 per million in low-income countries. This data reveals the growth scope for fiducial markers over the coming years.

Key Takeaways from Fiducial Markers Market Study

• Germany remains the leading country in the world’s largest market for fiducial - Europe
• The United States will remain the epicenter of the world’s largest fiducial markers market - North America - with a share of more than 85% in the region.

For detailed insights on enhancing your product footprint, request for a sample here - https://www.factmr.com/connectus/sample?flag=S&rep_id=1026

• China, Japan, Indonesia, and others to remain highly sought-after markets for suppliers.
• High demand for pure gold fiducial markers to fuel sales.
• Growing requirement of photon therapy to propel growth of fiducial manufacturers.
• In terms of disease site, prostate cancer to emerge as a dominant segment.
• Radiotherapy centers to lead market demand in terms of end user.

“With incorporation of cutting-edge technologies in modern healthcare systems, demand for fiducial markers has grown significantly in the past years, especially in radiotherapy. According to the report published by the International Journal of Medical Sciences, nearly 50% of all cancer patients receive radiation therapy during their course of illness, while it contributes towards 40% of curative treatment for cancer,” says a Fact.MR analyst.

For critical insights on this market, request for methodology here – https://www.factmr.com/connectus/sample?flag=RM&rep_id=1026

Rise in Cases of Cancer Fuelling Sales of Fiducial Markers

As fiducial markers are an integral part of radiation therapy for cancer patients, rise in cases of cancer is fuelling sales. As per a report published by The International Agency for Research on Cancer (IARC) in December 2020, globally, 1 in 5 people develop cancer during their lifetime, while the fatality rate is 1 in 8 for men and 1 in 11 for women. The report also stated that, more than 50 million people are living within 5 years of a past cancer diagnosis.

According to a report published by the World Health Organization (WHO) on 12th September 2018, cancer is the second-leading cause of death globally, and was responsible for an estimated 9.6 million deaths in 2018. While this data represents the high fatality rate of cancer, it also signifies huge demand for various medical devices and equipment for its diagnosis and treatment, of which, fiducial markers play a huge role.

For in-depth competitive analysis, buy now – https://www.factmr.com/checkout/1026/S

Who is Winning in this Space?

As key market players are investing more, competition is getting tougher gradually in the fiducial markers market space. In order to leverage new opportunities, key players are diversifying their products.

For instance,
• Boston Scientific launched its new LumiCoil™ Platinum Fiducial Markers, which are designed for clear visibility in CT, X-ray, EUS, and others, in January 2018.
• Stellar Medical launched its new range of fiducial markers, such as Stellar Gold Fiducial Markers, Soft Tissue Implantable Gold Fiducial Markers, and others, in 2019.

Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
E: sales@factmr.com
Website: https://www.factmr.com
Research Insight: https://www.factmr.com/report/1026/fiducial-marker-market
Content Source: https://www.factmr.com/media-release/1803/fiducial-markers-trend

About Us:

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global Fiducial Markers Market to Expand at over 8% CAGR Through 2031 | Eckert & Zieglar BEBIG, Innovative Oncology Solutions, Boston Scientific here

News-ID: 2268602 • Views:

More Releases from Fact.MR

Opioid Overdose Treatment Market Expansion Propelled by AstraZeneca, Bayer, Collegium Pharmaceutical, EMS Pharma, and GlaxoSmithKline
09-24-2025 | Health & Medicine
Fact.MR
Opioid Overdose Treatment Market Expansion Propelled by AstraZeneca, Bayer, Coll …
The global opioid overdose treatment market is poised for significant growth, driven by the rising prevalence of opioid use disorder and the escalating number of overdose-related fatalities worldwide. According to recent market insights, the market was valued at USD 1.54 billion in 2024 and is forecasted to grow at a CAGR of 7.2%, reaching a projected value of USD 3.1 billion by 2034. The expansion of the market is fueled
Liver Metastasis Treatment Market Growth Anchored by AstraZeneca; Bayer AG; Bristol-Myers Squibb Company; Cadila Pharmaceuticals Ltd.; Eli Lilly and Company;
09-24-2025 | Health & Medicine
Fact.MR
Liver Metastasis Treatment Market Growth Anchored by AstraZeneca; Bayer AG; Bris …
The global liver metastasis treatment market is experiencing significant growth due to rising prevalence of metastatic liver cancer and increasing awareness about advanced treatment options. According to recent market insights, the market was valued at USD 1,660 million in 2023 and is forecasted to expand at a CAGR of 6.5%, reaching an estimated value of USD 3,318.6 million by 2034. The growth is driven by rising incidence of liver metastasis,
Connected Vehicle Cloud Market Growing at a CAGR of 14% by 2034 | Siemens AG; Robert Bosch GmbH.; IBM Corporation; Amazon Web Services, Inc.; Cisco System,
Connected Vehicle Cloud Market Growing at a CAGR of 14% by 2034 | Siemens AG; Ro …
The connected vehicle cloud market is witnessing rapid growth, fueled by increasing integration of cloud technologies in automotive systems, rising demand for connected car services, and advancements in vehicle telematics and IoT-enabled solutions. According to recent market analysis, the global connected vehicle cloud market is projected to generate USD 48.49 billion in revenue in 2024 and is anticipated to expand at a CAGR of 14%, reaching a valuation of USD
Connected Home Security Market Set to Surge to USD 49.96 Billion by 2034 Led By Cisco Systems, Inc.; F-Secure Corporation; Avast Software; Trend Micro; Honeywell International Inc.; McAfee
Connected Home Security Market Set to Surge to USD 49.96 Billion by 2034 Led By …
The connected home security market is witnessing remarkable growth, driven by increasing adoption of smart home technologies, rising concerns over residential security, and the proliferation of IoT-enabled devices. According to recent analysis, the global market is expected to generate USD 9.97 billion in revenue in 2024, and is projected to expand at a CAGR of 17.5%, reaching a valuation of USD 49.96 billion by 2034. The robust growth trajectory is

All 5 Releases


More Releases for Fiducial

Fiducial Markers Market Insights, Forecast to 2031
This report has a complete table of contents, figures, tables, and charts, as well as insightful analysis. The Fiducial Markers market has been growing significantly in recent years, driven by a number of key factors, such as increasing demand for its products, expanding customer base, and technological advancements. This report provides a comprehensive analysis of the Fiducial Markers market, including market size, trends, drivers and constraints, competitive aspects, and prospects
Fiducial Markers Market Size 2024 to 2031.
Market Overview and Report Coverage Fiducial markers are small objects or substances used in medical imaging procedures to help guide and pinpoint the location of tumors or other significant areas within the body. These markers are commonly used in radiation therapy and image-guided surgeries. The future outlook for the Fiducial Markers Market is promising, with a projected growth rate of 19.00% during the forecasted period. Factors driving this growth include
Fiducial Markers Market: Insights, Trends, and Industry Forecast 2023-2032
In the ever-evolving landscape of medical technology, precision has become the cornerstone of advancements, especially in the realm of oncology. The Fiducial Markers Market stands as a testament to the growing importance of pinpoint accuracy in diagnostics and treatment planning. As we navigate the dynamics of this market, it becomes evident that fiducial markers are not merely tiny indicators; they are revolutionizing the precision in medical interventions. 𝐑𝐞𝐪𝐮𝐞𝐬𝐭 𝐒𝐚𝐦𝐩𝐥𝐞 𝐂𝐨𝐩𝐲 𝐨𝐟
Fiducial Markers Market Revenue, Company Profile, Key Trend Analysis & Forecast, …
Rising occurrence of cancer is one of the significant factors influencing the market growth. The global fiducial markers market is expected to reach USD 127.3 Million by 2027, according to a new report by Reports and Data. Fiducial markers find usage in image-guided radiotherapy procedures, where the placement of the markers is by modalities such as computed tomography (CT) or ultrasound, among others, and may encompass the application of an endoscope.
Fiducial Markers Market Playing Significant Growth During 2018 to 2028
XploreMR has published a new research report on fiducial markers market a new study of the fiducial markers market and published a report based on the forecast and trend analysis of the fiducial markers market for the forecast period of 2018 to 2028. The report on fiducial markers market unveils all the pivotal facets responsible for growth of fiducial markers market and also offers details for market players interested to
Fiducial Markers Market to Record Sturdy Growth by 2018 – 2028
Fiducial markers sales are anticipated to surpass 100 Mn by 2019, registering an upswing from 93.9 Mn in 2018, according to a Fact.MR study. As fiducial markers gain traction in parallel to rising incidences of various cancer forms affecting lung, prostate, abdomen and kidney, the growth potential of the market is set to witness a considerable rise. The escalating demand for fiducial markers can be accredited to, Growing adoption of radiotherapy